Downregulation of METTL7B Inhibits Proliferation of Human Clear Cell Renal Cancer Cells In Vivo and In Vitro

Clear cell renal cell carcinoma (ccRCC) is the most aggressive urologic tumor, and its incidence and diagonosis have been continuously increasing. Identifying novel molecular biomarker for inhibiting the progression of ccRCC will facilitate developing new treatment strategies. Although methyltransfe...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Wei, Xu, Shi, Peng, Naixiong, Zhang, Zejian, He, Hua, Chen, Ruoyu, Chen, Dong, Fan, Jiqing, Wang, Xisheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952878/
https://www.ncbi.nlm.nih.gov/pubmed/33718220
http://dx.doi.org/10.3389/fonc.2021.634542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952878/
https://www.ncbi.nlm.nih.gov/pubmed/33718220
http://dx.doi.org/10.3389/fonc.2021.634542

Ejemplares similares